In this webinar, our speakers Leticia Agúndez and Lucía San Miguel present the TAAV-manufactured enzymatic DNA process and product, featuring the advantages of the technology, such as regulatory benefits of using a bacterial-free DNA vector, leading to a more efficient and robust production.
The speakers discuss the quality control and assurance system that enables TAAV to provide a high quality product that can support an efficient rAAV manufacturing process throughout all phases of development from preclinical to clinical.
Watch it on-demand now: https://xtalks.com/webinars/raav-manufacturing-enzymatic-dna-for-achieving-a-robust-high-quality-dna-supply/